Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.45p
   
  • Change Today:
      0.000p
  • 52 Week High: 5.34p
  • 52 Week Low: 1.60p
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 92,322
  • Market Cap: £25.52m
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
13-Feb-25 Buy Anders Lundstrom 3.70p 575,000 £21,275.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
13-Feb-25 Buy Anders Lundstrom 3.70p 575,000 £21,275.00

Director Shareholdings

Notifier Holding Value*
Hans-Peter Hasler 5,500,000 £134,750
Anders Lundstrom 575,000 £14,088

Major Shareholders

Notifier** Holding Value*
AOP Orphan Pharmaceuticals AG 158,070,394 £3,872,725
Nutrition-Wellness Venture SA 56,008,541 £1,372,209
Jupiter Fund Management plc 34,127,697 £836,129
Premier Miton Group PLC 30,000,000 £735,000
MaRu AG 12,532,918 £307,056
JPMorgan Asset Management Holdings Inc. 6,238,846 £152,852
Universities Superannuation Scheme Ltd 5,067,985 £124,166
Spreadex Ltd 4,123,006 £101,014

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 2.45p
Change Today 0.000p
% Change 0.00 %
52 Week High 5.34p
52 Week Low 1.60p
Volume 92,322
Shares Issued 1,041.69m
Market Cap £25.52m
Beta 0.00

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.44% below the market average12.44% below the market average12.44% below the market average12.44% below the market average12.44% below the market average
73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average
Price Trend
33.25% below the market average33.25% below the market average33.25% below the market average33.25% below the market average33.25% below the market average
4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average
Income Not Available
Growth
62.54% above the market average62.54% above the market average62.54% above the market average62.54% above the market average62.54% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 29-May-2025

Time Volume / Share Price
11:57 75,000 @ 2.41p
09:58 52 @ 2.41p
09:45 42 @ 2.50p
09:45 2,017 @ 2.50p
09:45 179 @ 2.40p

STX Key Personnel

CEO Anders Lundstrom

Top of Page